The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Open accessAbstract
In Alzheimer's disease (AD), dementia severity correlates strongly with decreased synapse density in hippocampus and cortex. Numerous studies report that hippocampal long-term potentiation (LTP) can be inhibited by soluble oligomers of amyloid β-protein (Aβ), but the synaptic elements that mediate this effect remain unclear. We examined field EPSPs and whole-cell recordings in wild-type mouse hippocampal slices. Soluble Aβ oligomers from three distinct sources (cultured cells, AD cortex, or synthetic peptide) inhibited LTP, and this was prevented by the selective NR2B inhibitors ifenprodil and Ro 25-6981. Soluble Aβ enhanced NR2B-mediated NMDA currents and extrasynaptic responses; these effects were mimicked by the glutamate reuptake inhibitor dl -threo-β-benzyloxyaspartic acid. Downstream, an Aβ-mediated rise in p38 mitogen-activated protein kinase (MAPK) activation was followed by downregulation of cAMP response element-binding protein, and LTP impairment was prevented by inhibitors of p38 MAPK or calpain. Thus, soluble Aβ oligomers at low nanomolar levels present in AD brain increase activation of extrasynaptic NR2B-containing receptors, thereby impairing synaptic plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Self-citationShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Self-citationDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 2×
“Experimentally, soluble A oligomers (but not monomers) have been found to block hippocampal long-term potentiation (LTP), a synaptic correlate of memory and learning (Lambert et al., 1998; Walsh et al., 2002; Wang et al., 2002; Klyubin et al., 2005; Townsend et al., 2006; Shankar et al., 2007, 2008).”
BackgroundExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 24×
“Although some reports suggest that supraphysiological concentrations of synthetic A can enhance ERK and CREB phosphorylation within minutes (Dineley et al., 2001; Chong et al., 2006), the differences from our time course may relate to our natural sources of soluble A and our low concentrations, as found in AD brain ex…”
BackgroundInfluentialShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 3×
“We have no evidence that the soluble A oligomers bind directly to NR2B, to other NMDAR subunits, or indeed to any specific hydrophilic cell surface receptor, as discussed previously (Shankar et al., 2007, their Fig.”
BackgroundSelf-citationRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“The depressed synaptic NR2B proteins we observed at 6 h could be explained by endocytosis of surface NMDAR (Snyder et al., 2005) associated with A - mediated effects of excess glutamate levels (Vaslin et al., 2007).”
BackgroundResultSoluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Molecular diversity of the NMDA receptor channel
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,344
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Self-citationLu, W.-Y., Man, H.-Y., Ju, W., Trimble, W. S., MacDonald, J. F., & Wang, Y. T. (2001) · Neuron · doi:10.1016/s0896-6273(01)00194-5 · Cited by 910
The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Self-citationLiu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0116-07.2007 · Cited by 773 · cited 3×
“Accordingly, NR2Bselective antagonists effectively prevent glutamate-induced excitotoxicity in ischemia (Hardingham et al., 2002; Liu et al., 2007) and rescue A -inhibited LTP (Hu et al.”
BackgroundMassey, P. V., Johnson, B. E., Moult, P. R., Auberson, Y. P., Brown, M. W., Molnar, E., Collingridge, G. L., & Bashir, Z. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1697-04.2004 · Cited by 694
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Self-citationSaito, K., Elce, J. S., Hamos, J. E., & Nixon, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2628 · Cited by 583
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489 · cited 4×
“Experimentally, soluble A oligomers (but not monomers) have been found to block hippocampal long-term potentiation (LTP), a synaptic correlate of memory and learning (Lambert et al., 1998; Walsh et al., 2002; Wang et al., 2002; Klyubin et al., 2005; Townsend et al., 2006; Shankar et al., 2007, 2008).”
BackgroundInfluentialSelf-citationDineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04125.2001 · Cited by 462 · cited 1×
“Although some reports suggest that supraphysiological concentrations of synthetic A can enhance ERK and CREB phosphorylation within minutes (Dineley et al., 2001; Chong et al., 2006), the differences from our time course may relate to our natural sources of soluble A and our low concentrations, as…”
BackgroundWang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Self-citationOkamoto, S.-I., Pouladi, M. A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 436
Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine
Mayer, M. L., Vyklicky, L., & Clements, J. (1989) · Nature · doi:10.1038/338425a0 · Cited by 398
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 379
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · cited 1×
“In Alzheimer’s disease brain tissue, abnormally high levels of calpain (Saito et al.,1993) and p38 MAPK (Hensley et al., 1999; Sun et al.,2003) activation can be measured, perhaps even at an early stage in the disease process.”
BackgroundIvanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben‐Ari, Y., & Medina, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105510 · Cited by 319
Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway
Townsend, M., Mehta, T., & Selkoe, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610390200 · Cited by 318 · cited 1×
“…impairs ERK/CREB phosphorylation Our result that soluble A significantly inhibits ERK and CREB phosphorylation is consistent with a previous report (Townsend et al., 2007) that the inactivation of ERK/CREB signaling pathway by soluble A species secreted by cultured cells takes a few hours but can…”
ResultSelf-citationBeta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295 · cited 2×
“For example, synthetic fibrillar A , but not small synthetic A oligomers, can directly activate ERK phosphorylation (Sondag et al., 2009).”
BackgroundWalsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., Agnaf, O. E., Hartley, D. M., & Selkoe, D. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 286
Self-citationXu, J., Kurup, P., Zhang, Y., Goebel-Goody, S. M., Wu, P. H., Hawasli, A. H., Baum, M. L., Bibb, J. A., & Lombroso, P. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2212-09.2009 · Cited by 280
Harkany, T., Ábrahám, I., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 273
Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H., & Hardingham, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5019-04.2005 · Cited by 262
Rönicke, R., Mikhaylova, M., Rönicke, S., Meinhardt, J., Schröder, U. H., Fändrich, M., Reiser, G., Kreutz, M. R., & Reymann, K. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.011 · Cited by 247
Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 241
Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 223
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
Activation of AMPA, Kainate, and Metabotropic Receptors at Hippocampal Mossy Fiber Synapses
Min, M.-Y., Rusakov, D. A., & Kullmann, D. M. (1998) · Neuron · doi:10.1016/s0896-6273(00)80566-8 · Cited by 199
Zhou, M., & Baudry, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4299-05.2006 · Cited by 196
Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
Stanika, R. I., Pivovarova, N. B., Brantner, C. A., Watts, C. A., Winters, C. A., & Andrews, S. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903546106 · Cited by 193
Goebel-Goody, S. M., Davies, K. D., Alvestad Linger, R. M., Freund, R. K., & Browning, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.006 · Cited by 188
Imaging extrasynaptic glutamate dynamics in the brain
Okubo, Y., Sekiya, H., Namiki, S., Sakamoto, H., Iinuma, S., Yamasaki, M., Watanabe, M., Hirose, K., & Iino, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913154107 · Cited by 184
Chen, Q.-S., Wei, W.-Z., Shimahara, T., & Xie, C.-W. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4034 · Cited by 176
The Dichotomy of NMDA Receptor Signaling
Papadia, S., & Hardingham, G. E. (2007) · The Neuroscientist · doi:10.1177/10738584070130060401 · Cited by 176
Hu, N.-W., Klyubin, I., Anwyl, R., & Rowan, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908083106 · Cited by 171
Zhao, D., Watson, J. B., & Xie, C.-W. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00485.2004 · Cited by 168
Chronic Ethanol Induces Synaptic But Not Extrasynaptic Targeting of NMDA Receptors
Carpenter-Hyland, E. P., Woodward, J. J., & Chandler, L. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1902-04.2004 · Cited by 166
Chong, Y. H., Shin, Y. J., Lee, E. O., Kayed, R., Glabe, C. G., & Tenner, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601016200 · Cited by 165
Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors
von Engelhardt, J., Coserea, I., Pawlak, V., Fuchs, E. C., Köhr, G., Seeburg, P. H., & Monyer, H. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.015 · Cited by 162
Katagiri, H., Tanaka, K., & Manabe, T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01664.x · Cited by 159
Knobloch, M., Farinelli, M., Konietzko, U., Nitsch, R. M., & Mansuy, I. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0395-07.2007 · Cited by 136
Glutamate and other CSF amino acids in Alzheimer's disease
Pomara, N., Singh, R., Deptula, D., Chou, J., Schwartz, M. B., & LeWitt, P. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.2.251 · Cited by 126
Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice
Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 122
The role of NMDAR subtypes and charge transfer during hippocampal LTP induction
Berberich, S., Jensen, V., Hvalby, Ø., Seeburg, P. H., & Köhr, G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.016 · Cited by 117
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
Wu, J., Anwyl, R., & Rowan, M. J. (1995) · NeuroReport · doi:10.1097/00001756-199511270-00031 · Cited by 101
NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus
Raymond, C. R., Ireland, D. R., & Abraham, W. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02269-8 · Cited by 96
Gao, C., Gill, M. B., Tronson, N. C., Guedea, A. L., Guzmán, Y. F., Huh, K. H., Corcoran, K. A., Swanson, G. T., & Radulović, J. (2009) · Hippocampus · doi:10.1002/hipo.20705 · Cited by 96
Hu, N., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 94
Metabotropic Glutamate Receptor Mediated Long-term Depression in Developing Hippocampus
Overstreet‐Wadiche, L., Pasternak, J. F., Colley, P. A., Slater, N. T., & Trommer, B. L. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00031-2 · Cited by 87
Waxman, E. A., & Lynch, D. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502080200 · Cited by 87
Sinor, J. D., Du, S., Venneti, S., Blitzblau, R. C., Leszkiewicz, D. N., Rosenberg, P. A., & Aizenman, E. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08831.2000 · Cited by 85
Izumi, Y., Tokuda, K., & Zorumski, C. F. (2007) · Hippocampus · doi:10.1002/hipo.20383 · Cited by 80
Glutamate excitotoxicity in transient global cerebral ischemia
Paschen, W. (1996) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1996-1136 · Cited by 74
Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine
Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69 · cited 2×
“Interestingly, memantine, a NMDAR antagonist used to treat more advanced AD patients, has been shown to prevent A -mediated inhibition of LTP in rodents in vivo (Klyubin et al., 2011) and is mainly targeted to the extrasynaptic NMDAR (Milnerwood et al., 2010; Xia et al., 2010).”
BackgroundDomingues, A. M. D. J., Almeida, S., DACRUZESILVA, E., Oliveira, C. R., & Rego, A. C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.001 · Cited by 67
Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo
Molnár, Z., Soós, K., Lengyel, I., Penke, B., Szegedi, V., & Budai, D. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134471.06244.d2 · Cited by 61
Excitotoxicity‐related endocytosis in cortical neurons
Vaslin, A., Puyal, J., Borsello, T., & Clarke, R. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04564.x · Cited by 33
Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders
Marks, N., & Berg, M. J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.020 · Cited by 33
Mulholland, P. J., Luong, N. T., Woodward, J. J., & Chandler, L. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.001 · Cited by 31
O’Shea, S. D., Smith, I. M., McCabe, O., Cronin, M. M., Walsh, D. M., & O'Connor, W. T. (2008) · Sensors · doi:10.3390/s8117428 · Cited by 23
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Self-citation
Metadata
- Authors
- Li, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-05-04
- Volume
- 31
- Issue
- 18
- Pages
- 6627-6638
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2028174194
- Cited by
- 671
- References
- 73
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.